Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

CLOVER HEALTH INVESTMENTS, CORP. /DE

$3.92 +2.35% NASDAQ: CLOV · 15-min delayed
  • JERSEY CITY, New Jersey
  • Public · NASDAQ: CLOV
  • 724 employees
$2.0BMarket cap
$1.9BRevenue · FY2025
-$85.5MNet income
724Employees
CLOVNASDAQ
2021IPO

About CLOVER HEALTH INVESTMENTS, CORP. /DE

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$1.9B
Net income
-$85.5M
Total assets
$541.0M
Market cap
$2.0B
Operating margin
-4.4%
Net margin
-4.4%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$1.9B
Operating expenses
$2.0B
Operating income
-$85.5M
Income tax
$0
Net income
-$85.5M

Balance sheet

Total assets
$541.0M
Current assets
$307.9M
Total liabilities
$232.3M
Current liabilities
$208.8M
Shareholders’ equity
$308.7M

Cash flow

Operating cash flow
-$66.9M
Investing cash flow
$4.1M
Financing cash flow
-$53.4M
Net cash flow
-$116.2M

Statements via Polygon.io (SEC filings)

NASDAQ: CLOV
$3.92 +2.35%

15-minute delayed · data by Polygon.io

Past year

$1.70 $4.18

52-week range

Market cap
$2.0B
Shares outstanding
514.6M
Open
Day range
Prev close
Volume
IPO date
Jan 8, 2021

Market data by Polygon.io · prices are 15-minute delayed

Auto-generated

At a glance

  • Reported a net loss of $85.5M in FY2025.
  • Revenue grew 31% from FY2021 to FY2025.
  • Trading 6% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review CLOVER HEALTH INVESTMENTS, CORP. /DE.

Write a review
Newsroom

News about CLOVER HEALTH INVESTMENTS, CORP. /DE

News & sentiment via Polygon.io

Explore

Similar companies

Browse all →